Mendelson Daniel Newman
Director
1 company
Insider Signal Score
55
AverageTrades Analyzed
25
12M Win Rate
44.0%
Avg 3M Return
-9.9%
Avg 12M Return
+12.1%
Mendelson Daniel Newman is a Director at CHAMPIONS ONCOLOGY, INC.. Recent SEC Form 4 filings include 10 buys and 0 sells.
Estimated insider holdings value: $1.2M based on current market prices.
Holdings by Company
CSBRJan 12, 2024
Current Shares198.6K
Value$1.20M
Net Activity+813.4K
Bought: 826.8KSold: 13.3K
Transaction History
Showing 10 filings
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan 12, 2024 | CSBR Champions Oncology, Inc. | Director | Buy | 1,000 | $6.50 | $6,500.00 | +0.5% | -26.6% | +41.1% | |
| Jan 11, 2024 | CSBR Champions Oncology, Inc. | Director | Buy | 2,000 | $6.27 | $12,540.00 | +1.0% | -20.5% | +52.5% | |
| Jan 10, 2024 | CSBR Champions Oncology, Inc. | Director | Buy | 2,944 | $6.31 | $18,576.64 | +1.5% | -19.7% | +54.0% | |
| Jan 9, 2024 | CSBR Champions Oncology, Inc. | Director | Buy | 3,000 | $6.25 | $18,750.00 | +1.6% | -20.2% | +54.8% | |
| Jan 8, 2024 | CSBR Champions Oncology, Inc. | Director | Buy | 1,000 | $6.15 | $6,150.00 | +0.5% | -18.9% | +71.0% | |
| Jan 5, 2024 | CSBR Champions Oncology, Inc. | Director | Buy | 2,000 | $6.09 | $12,180.00 | +1.1% | -18.0% | +60.7% | |
| Jan 4, 2024 | CSBR Champions Oncology, Inc. | Director | Buy | 3,000 | $6.12 | $18,360.00 | +1.6% | -17.8% | +59.7% | |
| Jan 3, 2024 | CSBR Champions Oncology, Inc. | Director | Buy | 500 | $5.83 | $2,915.00 | +0.3% | -17.6% | +33.3% | |
| Dec 21, 2023 | CSBR Champions Oncology, Inc. | Director | Buy | 2,500 | $4.92 | $12,300.00 | +1.4% | +12.0% | +52.9% | |
| Dec 20, 2023 | CSBR Champions Oncology, Inc. | Director | Buy | 2,100 | $4.82 | $10,122.00 | +1.2% | +2.6% | +51.9% |
Page 1Next →